The mobile health industry has undergone profound transformations over the last decade, as it continues to forge a new path for the medical industry and play a role in reforming the regulatory landscape. While there have been a multitude of successes throughout the mobile health industry, there have also been several challenges that healthcare providers and lawmakers continue to address.

The American Enterprise Institute (AEI) states that the Food and Drug Administration (FDA) is not taking part in defining what mobile health apps should be regulated, which agencies or experts should be handling the regulations, and how to enforce the correct actions.

This type of inaction could lead to a delay in the product coming to market. These challenges need to be overcome by including more regulation and oversight from the FDA and other regulatory agencies throughout the country.

However, the FDA can assist the mobile health industry in making headway in patient care, better outcomes, and more data capabilities by developing a more cohesive regulatory process and promoting innovation within this particular field.

Source: mhealthintelligence.com